Peter Hein
- Oncology top 5%
- Cancer Research top 5%
- Urology top 5%
- Urinary Bladder and Prostate Research 3
-
- Neuropeptides and Animal Physiology 6
- Neuroscience and Neuropharmacology Research 5
- Molecular Biology top 10%
- Receptor Mechanisms and Signaling 18
- Ion channel regulation and function 3
-
- Liver Disease Diagnosis and Treatment 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
-
- Nitric Oxide and Endothelin Effects 2
- Co-authors
- PR CarrollCunha GrTD TlstyMoritz BünemannMartin J. LohseMartin C. MichelCarsten HoffmannViacheslav O. Nikolaev
- Cited by
- OncologyCancer ResearchUrology
- Journals
- Naunyn-Schmiedeberg s Archives of Pharmacology (4 papers)Drug Discovery Today (3 papers)PLoS ONE (3 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Peter Hein
32 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 688
- Cancer Research 364
- Urology 147
- Cellular and Molecular Neuroscience 401
- Molecular Biology 1.2k
Countries citing papers authored by Peter Hein
This map shows the geographic impact of Peter Hein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hein more than expected).
Fields of papers citing papers by Peter Hein
This network shows the impact of papers produced by Peter Hein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hein. The network helps show where Peter Hein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Hein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2020 | 18 | |
| 5 | 2020 | 10 | |
| 6 | 2019 | 17 | |
| 7 | 2018 | 9 | |
| 8 | 2012 | 27 | |
| 9 | 2011 | 17 | |
| 10 | 2010 | 5 | |
| 11 | 2008 | 78 | |
| 12 | 2006 | 45 | |
| 13 | 2006 | 112 | |
| 14 | 2005 | 181 | |
| 15 | 2005 | 41 | |
| 16 | 2001 | 27 | |
| 17 | 2001 | 18 | |
| 18 | Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epitheliumbreakdown → | 2000 | 1219 |
| 19 | 2000 | 1 | |
| 20 | 1990 | 13 |
About Peter Hein
Peter Hein is a scholar working on Cellular and Molecular Neuroscience, Urology, Molecular Biology, Physiology and Physiology, having authored 34 papers that have together received 2.1k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (18 papers), Neuropeptides and Animal Physiology (6 papers), Neuroscience and Neuropharmacology Research (5 papers), Liver Disease Diagnosis and Treatment (3 papers), Ion channel regulation and function (3 papers), Urinary Bladder and Prostate Research (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Nitric Oxide and Endothelin Effects (2 papers). The work is most often cited by research in Oncology (688 citations), Cancer Research (364 citations), Urology (147 citations), Cellular and Molecular Neuroscience (401 citations) and Molecular Biology (1.2k citations). Peter Hein has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include PR Carroll, Cunha Gr, TD Tlsty, Moritz Bünemann, Martin J. Lohse, Martin C. Michel, Carsten Hoffmann, Viacheslav O. Nikolaev, Tim Schneider and Monika Frank. Their work appears in journals such as Naunyn-Schmiedeberg s Archives of Pharmacology, Drug Discovery Today, PLoS ONE, International Journal of Legal Medicine and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.